<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the effect of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, the most common defect of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> conjugation, on the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels of subjects with inherited <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> which cause <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> production </plain></SENT>
<SENT sid="1" pm="."><plain>57 patients heterozygous for <z:e sem="disease" ids="C0005283" disease_type="Disease or Syndrome" abbrv="">beta-thalassaemia</z:e>, 21 with <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G6PD deficiency</z:e> and 44 controls were examined by typing the TATA-box in the promoter of the gene <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi> glucuronosyltransferase 1A </plain></SENT>
<SENT sid="2" pm="."><plain>Nearly 80% of patients with <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> levels were heterozygous or homozygous for the UGT1A TA(7) variant associated with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>These findings indicate that <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> accounts for a large proportion of the variability of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels in <z:e sem="disease" ids="C0005283" disease_type="Disease or Syndrome" abbrv="">beta-thalassaemia</z:e> and <z:e sem="disease" ids="C0017758" disease_type="Disease or Syndrome" abbrv="">G6PD deficiency</z:e> </plain></SENT>
</text></document>